CanRIO Projects

CanRIO Recommendations for the Assessment and Management of Rheumatic Immune Related Adverse Events from Cancer Immunotherapy

Posted January 22, 2021
Coming 2021! With support from the Canadian Rheumatology Association (CRA) Guidelines Committee, CanRIO has assembled a working group of rheumatologists, oncologist and patient representative to… Read More

A Prospective Cohort Study of Adults with Rheumatic Immune Related Adverse Events associated with Cancer Immunotherapies (CanRIO)

Posted January 4, 2021
Currently recruiting! This is an ongoing prospective, multi-centre, Canadian study looking at clinical phenotypes, outcomes and biomarker profiles of adults with rheumatic immune related adverse… Read More